Literature DB >> 15946748

Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance.

Jerry J Buccafusco1, Sharon R Letchworth, Merouane Bencherif, Patrick M Lippiello.   

Abstract

Agonists of nicotinic acetylcholine receptors (nAChRs) produce long-lasting cognitive effects in animal models and humans. The duration of these cognitive effects can outlast the presence of the agonists in the system, and the persistence of cognitive enhancement is increased further by repeated exposure. The basis for this discrepancy appears be the cellular and systemic mechanisms of learning and memory. Agonists of nAChRs induce long-term potentiation (LTP), which is a strengthening of synaptic connections that is associated with learning and memory formation. Some of the cellular effects of nAChR agonists overlap with the known cellular mechanisms of LTP, including long-lasting increases in intracellular concentrations of Ca2+, activation of second-messenger systems and transcription factors, elevated levels of gene products and enhanced neurotransmitter release. A better understanding of this phenomenon might shed new light on the role of nAChR systems in memory formation and retrieval.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15946748     DOI: 10.1016/j.tips.2005.05.007

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  50 in total

Review 1.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

2.  Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers.

Authors:  G Dunbar; P H Boeijinga; A Demazières; C Cisterni; R Kuchibhatla; K Wesnes; R Luthringer
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

Review 3.  Multifunctional receptor-directed drugs for disorders of the central nervous system.

Authors:  Jerry J Buccafusco
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

Review 4.  Therapeutic strategies for Alzheimer's disease.

Authors:  Donna M Barten; Charles F Albright
Journal:  Mol Neurobiol       Date:  2008-06-26       Impact factor: 5.590

5.  Anti-inflammatory effect and mechanism of the spirocyclopiperazinium salt compound LXM-15 in rats and mice.

Authors:  Xiaoli Gao; Qi Sun; Weiwei Zhang; Yimin Jiang; Runtao Li; Jia Ye
Journal:  Inflamm Res       Date:  2018-01-04       Impact factor: 4.575

Review 6.  Neurobiology of nAChRs and cognition: a mini review of Dr. Jerry J. Buccafusco's contributions over a 25 year career.

Authors:  Alvin V Terry; Michael W Decker
Journal:  Biochem Pharmacol       Date:  2011-06-12       Impact factor: 5.858

7.  Dietary choline supplementation improves behavioral, histological, and neurochemical outcomes in a rat model of traumatic brain injury.

Authors:  Maria V Guseva; Deann M Hopkins; Stephen W Scheff; James R Pauly
Journal:  J Neurotrauma       Date:  2008-08       Impact factor: 5.269

8.  A critical examination of best dose analysis for determining cognitive-enhancing potential of drugs: studies with rhesus monkeys and computer simulations.

Authors:  Paul L Soto; Jesse Dallery; Nancy A Ator; Brian R Katz
Journal:  Psychopharmacology (Berl)       Date:  2013-03-26       Impact factor: 4.530

9.  A novel nicotinic mechanism underlies β-amyloid-induced neuronal hyperexcitation.

Authors:  Qiang Liu; Xitao Xie; Ronald J Lukas; Paul A St John; Jie Wu
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

10.  Activation of functional α7-containing nAChRs in hippocampal CA1 pyramidal neurons by physiological levels of choline in the presence of PNU-120596.

Authors:  Bopanna I Kalappa; Alexander G Gusev; Victor V Uteshev
Journal:  PLoS One       Date:  2010-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.